PATENT CLAIM ANALYSIS

Application Number: 15904408
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["435", "320100"]

Abstract:
A subgroup B recombinant human adenovirus vector Ad 11 - 5 EP (SEQ ID NO: 1), which is constructed by a method including: substituting a 365 bp fragment containing an enhancer and a promoter of an upstream coding sequence of Ad5 E1A (SEQ ID NO: 2) for a corresponding region of a serotype Ad11 (SEQ ID NO: 3) of a subgroup B human adenovirus vector by homologous recombination to construct the subgroup B recombinant human adenovirus vector Ad11-5EP (SEQ ID NO: 1).

Claim (Index 1):
A subgroup B recombinant human adenovirus vector Ad11-5EP (SEQ ID NO: 1), wherein the subgroup B recombinant human adenovirus vector Ad11-5EP (SEQ ID NO: 1) is constructed by a method comprising substituting a 365 bp fragment comprising an enhancer and a promoter of an upstream coding sequence of Ad5 E1A (SEQ ID NO: 2) for a corresponding region of a serotype Ad11 (SEQ ID NO: 3) of a subgroup B human adenovirus vector by homologous recombination to construct the subgroup B recombinant human adenovirus vector Ad11-5EP (SEQ ID NO: 1).

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 1.73214
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14093078', '15098342', '14648661', '11288821', '13892789']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.594141973373429
- 35 USC 102 Novelty (BERT): 0.6559727209755489
- Combined Prediction Score: 0.6003250481336411
- Mean Citation Score: 421.759256
- Max Citation Score: 629.7642
- Similarity Product: 613.7197399695398

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test